Nxera Pharma Co Ltd (SOLTF)
9.72
0.00 (0.00%)
USD |
OTCM |
Apr 18, 16:00
Nxera Pharma Shareholders Equity (Quarterly): 473.75M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 473.75M |
September 30, 2023 | 387.94M |
June 30, 2023 | 432.74M |
March 31, 2023 | 436.90M |
December 31, 2022 | 441.88M |
September 30, 2022 | 385.56M |
June 30, 2022 | 412.66M |
March 31, 2022 | 463.39M |
December 31, 2021 | 499.40M |
September 30, 2021 | 480.35M |
June 30, 2021 | 504.37M |
March 31, 2021 | 498.73M |
December 31, 2020 | 507.89M |
September 30, 2020 | 456.40M |
June 30, 2020 | 380.49M |
March 31, 2020 | 390.68M |
December 31, 2019 | 413.92M |
September 30, 2019 | 392.95M |
June 30, 2019 | 384.45M |
March 31, 2019 | 393.49M |
September 30, 2018 | 401.26M |
June 30, 2018 | 420.42M |
March 31, 2018 | 459.98M |
December 31, 2017 | 449.26M |
September 30, 2017 | 276.36M |
Date | Value |
---|---|
June 30, 2017 | 271.50M |
March 31, 2017 | 253.60M |
December 31, 2016 | 261.61M |
September 30, 2016 | 269.91M |
June 30, 2016 | 284.48M |
March 31, 2016 | 205.89M |
December 31, 2015 | 246.38M |
September 30, 2015 | 192.64M |
June 30, 2015 | 131.57M |
March 31, 2015 | 121.63M |
December 31, 2014 | 126.03M |
September 30, 2014 | 132.97M |
June 30, 2014 | 140.16M |
March 31, 2014 | 139.49M |
December 31, 2013 | 60.45M |
September 30, 2013 | 66.40M |
June 30, 2013 | 59.09M |
March 31, 2013 | 84.41M |
December 31, 2012 | 78.35M |
September 30, 2012 | 85.87M |
June 30, 2012 | 77.90M |
March 31, 2012 | 82.54M |
December 31, 2011 | 95.30M |
September 30, 2011 | 104.13M |
June 30, 2011 | 100.96M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
380.49M
Minimum
Jun 2020
507.89M
Maximum
Dec 2020
439.18M
Average
436.90M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 47.81B |
PeptiDream Inc | 286.12M |
Stemcell Holdings Inc | 6.009M |
Healios KK | 27.34M |
AnGes Inc | 185.10M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.115B |
Total Liabilities (Quarterly) | 640.94M |
Debt to Equity Ratio | 1.035 |
Current Ratio | 3.789 |
Net Debt Paydown Yield | -6.66% |